FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gastroenterology and hepatology. It can be used for prediction of liver cirrhosis in patients with chronic hepatitis C. Patient's blood serum enzyme immunoassay is used to determine the quantitative values of osteopontin and hepatocyte growth factor. If observing values of osteopontin above 23 ng/ml and hepatocyte growth factor above 935 ng/ml, a risk of developing hepatic cirrhosis is predicted.
EFFECT: method is non-invasive, accessible, provides the timely selection of the optimal approach to the antifibrotic therapy.
2 cl, 6 dwg, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B AND CHRONIC HEPATITIS C IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2835987C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS C AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834898C1 |
| DIAGNOSTIC TECHNIQUE FOR CIRRHOTIC STAGE OF CHRONIC VIRAL HEPATITIS C | 2014 |
|
RU2563129C1 |
| METHOD OF PREDICTING AN INCREASED RISK OF DECOMPENSATION OF LIVER CIRRHOSIS OR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH LIVER CIRRHOSIS IN THE OUTCOME OF CHRONIC HEPATITIS C AFTER ACHIEVING A SUSTAINED VIROLOGIC RESPONSE | 2022 |
|
RU2800251C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B, CHRONIC HEPATITIS C AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834902C1 |
| METHOD FOR DIAGNOSING FIBROSIS F4 IN PATIENTS WITH CHRONIC LIVER DISEASES | 2024 |
|
RU2827360C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC HEPATITIS B AND AUTOIMMUNE LIVER DISEASES IN PATIENTS WITH SEVERE FIBROSIS AND CIRRHOSIS | 2024 |
|
RU2834900C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
| METHOD FOR DIAGNOSING MODERATE AND PRONOUNCED SEVERITY OF LIVER INFLAMMATION, CORRESPONDING TO A HISTOLOGICAL ACTIVITY INDEX OF 9 POINTS OR MORE, IN PATIENTS WITH CHRONIC LIVER DISEASES | 2024 |
|
RU2835446C1 |
| NONINVASIVE METHOD FOR DIAGNOSING HEPATIC FIBROSIS GRADE IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2261441C2 |
